---
figid: PMC6592288__oncotarget-10-4038-g005
figlink: /pmc/articles/PMC6592288/figure/F5/
number: F5
caption: Blue labeling, tumor suppressors and inhibitory signaling; punctate line,
  negative feedback; red labeling, oncogenic proteins and activating signaling; purple,
  p85α (PIK3R1) with dual function; green, signaling lipids; bold letters, the proteins
  mutated in SEGA-like periventricular glioblastoma (NF1, TSC1 and mTOR from this
  study, and B-Raf from [, ]); underlined, some other mutated proteins contributing
  to the high grade phenotype; circled, the oncogenic proteins with FDA-approved drug
  inhibitors; black labeling, cellular effects of the pathways. Note the marked anabolic
  and biogenetic effects of the mTOR pathway that most likely induce the epithelioid/SEGA-like
  appearance of the cells in these tumors.
pmcid: PMC6592288
papertitle: Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma
  with epithelioid SEGA-like morphology–morphological and therapeutic implications.
reftext: Maria-Magdalena Georgescu, et al. Oncotarget. 2019 Jun 18;10(40):4038-4052.
pmc_ranked_result_index: '8878'
pathway_score: 0.9684932
filename: oncotarget-10-4038-g005.jpg
figtitle: Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma
  with epithelioid SEGA-like morphology–morphological and therapeutic implications
year: '2019'
organisms: Homo sapiens
ndex: 12bd06b5-dec6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6592288__oncotarget-10-4038-g005.html
  '@type': Dataset
  description: Blue labeling, tumor suppressors and inhibitory signaling; punctate
    line, negative feedback; red labeling, oncogenic proteins and activating signaling;
    purple, p85α (PIK3R1) with dual function; green, signaling lipids; bold letters,
    the proteins mutated in SEGA-like periventricular glioblastoma (NF1, TSC1 and
    mTOR from this study, and B-Raf from [, ]); underlined, some other mutated proteins
    contributing to the high grade phenotype; circled, the oncogenic proteins with
    FDA-approved drug inhibitors; black labeling, cellular effects of the pathways.
    Note the marked anabolic and biogenetic effects of the mTOR pathway that most
    likely induce the epithelioid/SEGA-like appearance of the cells in these tumors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF4EBP1
  - MAPK3
  - CDK4
  - AKT3
  - AKT1
  - AKT2
  - FOXO3
  - GSK3A
  - GSK3B
  - KRAS
  - MAP2K1
  - MAP2K2
  - MTOR
  - RPTOR
  - NF1
  - CDKN2A
  - FOXO4
  - FOXO6
  - FOXO1
  - ARAF
  - RAF1
  - BRAF
  - RPS6KA1
  - HRAS
  - NRAS
  - RHEB
  - PIK3R1
  - PTEN
  - MAPK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CDK4/6)CyclinD1
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: Raf/B-Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf/B-Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf/B-Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RSK1
  symbol: RSK1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RheB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: p85a.
  symbol: p85-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: PIK3R1
  entrez: '5295'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf/B-Raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6592288__F5
redirect_from: /figures/PMC6592288__F5
figtype: Figure
---
